Fecal Calprotectin in Cystic Fibrosis

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00863694

Enrollment

106

Registered

2009-03-18

Start date

2009-02-28

Completion date

2013-08-31

Last updated

2013-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cystic Fibrosis

Keywords

cystic fibrosis, calprotectin, elastase

Brief summary

Elevated fecal calprotectin is a biomarker for intestinal inflammation in cystic fibrosis

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

1 Months to No maximum

Healthy volunteers

Inclusion criteria

* All patients

Exclusion criteria

* Informed consent/assent not obtained

Design outcomes

Primary

Measure	Time frame
collection of 150 stool specimens	2 years

Countries

United States

Outcome results